United Healthcare (UHC) Medical Policy Updates – January 2023

Click here to view the United Healthcare (UHC) Medical Policy Updates »

• Antiemetics for Oncology
• Assisted Administration of Clotting Factors, Coagulant Blood Products & Other Hemostatics (for Oxford Only)
• Brow Ptosis and Eyelid Repair
• Catheter Ablation for Atrial Fibrillation
• Clinical Trials
• Denosumab (Prolia ®& Xgeva®)
• Durable Medical Equipment, Orthotics, Ostomy Supplies, Medical Supplies and Repairs/Replacements
• Electrical Stimulation for the Treatment of Pain and Muscle Rehabilitation
• Eloctate  [Antihemophilic Factor (Recombinant), FC Fusion Protein] for Connecticut Lines of Business (for Oxford Only)
• Environmental Allergen Immunotherapy
• Evenity™ (Romosozumab-Aqqg)
• Gender Dysphoria Treatment
• Genetic Testing for Hereditary Cancer
• Glaucoma Surgical Treatments
• Habilitative Services and Outpatient Rehabilitation Therapy
• Hearing Aids and Devices Including Wearable, Bone-Anchored and Semi-Implantable
• Hepatitis Screening
• Ilumya™ (Tildrakizumab-Asmn)
• Immune Globulin – Site of Care
• Immune Globulin (IVIG and SCIG)
• Intravenous Iron Replacement Therapy (Feraheme®, Injectafer®, & Monoferric®)
• Leqvio  (Inclisiran)
• Lower Extremity Endovascular Procedures
• Maximum Dosage
• Medical Records Requirements for Pre-Service
• Molecular Oncology Testing for Cancer Diagnosis, Prognosis, and Treatment Decisions
• Obstetrical Ultrasound
• Oncology Medication Clinical Coverage
• Outpatient Surgical Procedures – Site of Service
• Oxlumo  (Lumasiran)
• PDF: mpub-archive-uhc.pdf
• PDF: radiation-therapy-fractionation-image-special-services.pdf
• Percutaneous Neuroablation for Severe Cancer Pain and Trigeminal Neuralgia
• Pharmacogenetic Testing
• Preventive Care Services
• Prostate Surgeries and Interventions
• Provider Administered Drugs – Site of Care
• Review at Launch for New to Market Medications
• Rhinoplasty and Other Nasal Surgeries
• RNA-Targeted Therapies (Amvuttra™ and Onpattro )
• Sacroiliac Joint Interventions
• Saphnelo (Anifrolumab-Fnia)
• Screening Colonoscopy Procedures – Site of Service
• Skyrizi  (Risankizumab-Rzaa)
• Somatostatin Analogs
• Subcutaneous Implantable Naltrexone Pellets
• Surgical Treatment of Lymphedema
• Testosterone Replacement or Supplementation Therapy
• Tezspire  (Tezepelumab-Ekko)
• Total Artificial Disc Replacement for the Spine
• Visual Information Processing Evaluation and Orthoptic and Vision Therapy
• Xiaflex  (Collagenase Clostridium Histolyticum)

Click here to view the United Healthcare (UHC) Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.